OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Liver Disease is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Navigating the Management of Hepatocellular Carcinoma	410
Forthcoming Issues	68
Forthcoming Issues	44
Copyright	41
Special Population	36
The Role of Liver Transplantation in Hepatocellular Carcinoma	36
Forthcoming Issues	36
Contributors	35
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease	30
Forthcoming Issues	29
Primary Biliary Cholangitis	28
Recurrent and De Novo Liver Disease After Liver Transplantation	28
Artificial Intelligence and Machine Learning Applications in Liver Disease	23
Pathogenesis of Alcohol-Associated Liver Disease	22
Contents	22
Overview of New Targets for Hepatitis B Virus	21
Preface	21
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment	20
What is the Path Forward to Treat Hepatitis Delta Virus?	19
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination	19
Preface	18
Consultations in Liver Disease	17
Nonalcoholic Fatty Liver Disease in Latin America and Australia	17
Primary Biliary Cholangitis	17
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	16

Portal Hypertension and its Complications	16
The Diagnostic Pathway for Patients with Cholestatic Liver Disease	16
Contributors	15
Copyright	14
Alcohol-Associated Liver Disease	14
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings	14
Recent Advances in Primary Biliary Cholangitis Treatment	13
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia	13
Targeting Hepatitis B Virus DNA Using Designer Gene Editors	13
Primary Sclerosing Cholangitis	13
Minimal Hepatic Encephalopathy	13
Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America	12
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease	11
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis	11
General Hepatology Concerns for the Patient with Cholestatic Liver Disease	11
Biliary Atresia in Children	11
The Liver in Diabetes and Metabolic Syndrome	10
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats	10
Prognostic Scoring Systems in Primary Biliary Cholangitis	10
Pharmacologic Management of Hepatic Encephalopathy	10
The Liver in Hematologic Malignancies	10
Current and Next-Generation Therapeutics in Hepatology	10
Beyond the Liver	10
Copyright	10
Treatment of Primary Sclerosing Cholangitis Including Transplantation	9
Hepatitis B and C in Children	9
Navigating Hepatocellular Carcinoma	9
Hepatocellular Carcinoma	9
Copyright	9
Alcohol Use Disorder	9
Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease	9
Novel Therapies in Primary Biliary Cholangitis	9
Acute Alcoholic Hepatitis	9
Contents	9
Chronic Hepatitis B	8
Contents	8
Hepatic Encephalopathy	8
Disparities in Alcohol-Related Liver Disease	8
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?	8
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis	8
Preventing Readmissions for Hepatic Encephalopathy	8
Overview of Progressive Familial Intrahepatic Cholestasis	8
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape	8
State of the Art	8
Disease Modulating Agents in Cirrhosis	8
Forthcoming Issues	8
Primary Biliary Cholangitis	8
Contents	8
Alcohol-Related Liver Disease	8
Amyloidosis and the Liver	8

Renal Insufficiency in Patients with Cirrhosis	8
Chronic Hepatitis B Virus and Hepatitis D Virus	7
Systemic Complications of Primary Biliary Cholangitis	7
Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean	7
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis	7
Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis	7
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease	7
Genetics of Primary Biliary Cholangitis	7
Contributors	7
Hepatic Encephalopathy in Acute-on-Chronic Liver Failure	7
Alagille Syndrome	7